Akebia Therapeutics, Inc. (AKBA) vs Invivyd, Inc. (IVVD)

A side-by-side comparison of Akebia Therapeutics, Inc. and Invivyd, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AKBA vs IVVD

growth of $100 · dividends reinvested · last 5y
AKBA -64.6% (-18.7%/yr)IVVD -96.0% (-47.4%/yr)AKBA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$35$4
AKBA IVVD

AKBA vs IVVD: by the numbers

  • •IVVD is the larger company ($251M vs $237M market cap).
  • •Both run net losses; AKBA's is the smaller (-13.54% vs -183.90% net margin).

Metrics side by side

Valuation

MetricAKBAIVVD
P/S ratio1.084.31
P/B ratio9.471.39
FCF yield16.96%N/A

Profitability

MetricAKBAIVVD
Gross margin79.48%91.35%
Operating margin9.95%-103.99%
Net margin-13.54%-183.90%
ROE-118.58%-59.27%
ROIC-7.08%-59.90%

Growth (annualized)

MetricAKBAIVVD
Revenue CAGR (5Y)-0.26%N/A
Total return CAGR (5Y)-20.07%-51.69%

Frequently asked

How have AKBA and IVVD total returns compared?
Over the past 5 years, AKBA delivered -20.07% and IVVD delivered -51.69% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.